AI assistant
Cigna Group — Director's Dealing 2023
Mar 1, 2023
29918_dirs_2023-02-28_adf14161-19ed-440c-933b-96e15e7f17fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2023-02-24
Reporting Person: Neville Everett (EVP, Solutions & Corp Devt.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-24 | Common Stock, $.01 Par Value | A | 4694.0000 | $0.0000 | Acquired | 13241.0000 | Direct |
| 2023-02-24 | Common Stock, $.01 Par Value | F | 228.0000 | $294.2700 | Disposed | 13013.0000 | Direct |
| 2023-02-24 | Common Stock, $.01 Par Value | F | 1683.0000 | $294.2700 | Disposed | 11330.0000 | Direct |
| 2023-02-27 | Common Stock, $.01 Par Value | S | 1772.0000 | $294.0600 | Disposed | 9558.0000 | Direct |
Footnotes
F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022.